Rankings
▼
Calendar
BCYC FY 2018 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
+246.4% YoY
Gross Profit
-$14M
-190.9% margin
Operating Income
-$22M
-304.7% margin
Net Income
-$22M
-306.1% margin
EPS (Diluted)
$-1.64
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$27M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$82M
Total Liabilities
$151M
Stockholders' Equity
-$70M
Cash & Equivalents
$63M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$2M
+246.4%
Gross Profit
-$14M
-$10M
-38.9%
Operating Income
-$22M
-$16M
-34.1%
Net Income
-$22M
-$16M
-34.4%
← Q4 2017
All Quarters
Q1 2018 →